Driscoll pharmacist appointed Congressional Captain

Community NewsPublisher's Picks
232

Translate to Spanish or other 102 languages!

Jennifer Witte, PharmD is shown here with Congressman Michael Cloud, U.S. Representative for the 27th District of Texas

Mega Doctor News

- Advertisement -

Jennifer Witte, PharmD, a dedicated cystic fibrosis clinical pharmacist for the Driscoll Children’s Hospital Cystic Fibrosis Center who is certified by the Society of Infectious Diseases Pharmacists (SIDP) in antimicrobial stewardship, was recently appointed the Congressional Captain for TX-27 by the Cystic Fibrosis Foundation CF Advocacy Department. She is shown here with Congressman Michael Cloud, U.S. Representative for the 27th District of Texas. They met to discuss cystic fibrosis and the PASTEUR Act, which is a bill introduced to the House and Senate that aims to improve antimicrobial stewardship and the development of antibiotics.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Dr. Hochman Funds Twentieth Annual Education Grant
Next article
Drugs used by some Type 2 diabetics may lessen their risk for severe COVID-19 complications

More Articles

Social Security Administration Corrects Millions of Records in Major Database Cleanup

The Social Security Administration (SSA) announced on October 20, 2026, that it has corrected millions of Social Security number records in what the agency describes as its most comprehensive record-integrity initiative in 91 years.

Dr. Lisa Chapa Explains Why Not Every Breast Lump Is Cancer

 Discovering a lump in the breast can cause immediate concern, but many breast abnormalities are not cancerous, according to Dr. Lisa Chapa, a breast surgeon who explained how physicians distinguish benign conditions from breast cancer.

DHR Health Expands Behavioral Health Team with Dr. Alexandra Treviño, Psychiatrist

 DHR Health, the largest provider of specialty healthcare in the Rio Grande Valley, is pleased to announce that Dr. Alexandra Treviño, has joined its team of physicians.

New Breast Cancer Treatments Offer More Personalized Options for Patients in 2026

Advances in genetic testing and clinical research are giving physicians new ways to select breast cancer treatments based on individual patients' needs, according to Dr. Joseph Murray, senior medical director at Caris Life Sciences
- Advertisement -